title: Therapeutic strategies for laryngeal manifestations of gastroesophageal reflux disease.
abstract: Gastroesophageal reflux disease is increasingly associated with ear, nose, and throat symptoms, including laryngitis. Many patients are unaware of the gastroesophageal etiology of their symptoms. A variety of criteria are used to diagnose this condition, including laryngoscopy, esophagogastroduodenoscopy, and the use of ambulatory pH and impedance monitoring. However, no test serves as the gold standard for the diagnosis given their lack of sensitivity and specificity for reflux disease. Numerous trials have assessed the role of proton pump inhibitor therapy in patients with laryngopharyngeal reflux and most have revealed no benefit to acid suppression over placebo. Despite many uncertainties there has been some progress regarding the role of acid-suppressive therapy as well as other agents in this unique group of patients. In this review we explore therapeutic options and their rationale for patients with laryngeal signs and symptoms.
authors: Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt Medical Center, Nashville, TN 37232-5280, USA.
authors: Elif S
authors: ES
authors: Yuksel
authors: Michael F
authors: MF
authors: Vaezi
mesh_terms: D000818:Animals; D017097:Electric Impedance; D016145:Endoscopy, Digestive System / Q000379:methods; D050782:Esophageal pH Monitoring; D005764:Gastroesophageal Reflux / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007827:Laryngitis / Q000175:diagnosis / Q000209:etiology*; D057045:Laryngopharyngeal Reflux / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D007828:Laryngoscopy / Q000379:methods; D054328:Proton Pump Inhibitors / Q000627:therapeutic use; D012680:Sensitivity and Specificity
chemical_list: D054328:Proton Pump Inhibitors